BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Bank of America Merrill Lynch
|Closed|| Long (1Y)
Bank of America Merrill Lynch maintains buy on Cipla
The brokerage says, Cipla may triple its sales by FY20 and limited competition drug to drive its growth. In an optimistic situation net profit of the company can jump five times, adds the brokerage.